Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion type Assertion NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_head.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion wasGeneratedBy ECO_0000218 NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_provenance.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion wasDerivedFrom ctd_human-20130708 NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_provenance.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion SIO_000772 17015054 NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_provenance.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion evidence source_evidence_curated NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_provenance.
- NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_assertion description "[MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7246.RAWv02Dr4OlMwt1E7XB9_ZUodXeA-LFPcTCj4jcAcsjmI130_provenance.